News

IDIBELL, University Hospital of Bellvitge and UPC collaborate to develop new health technologies

IDIBELL, University Hospital of Bellvitge and the Polytechnic University of Catalonia (UPC) have signed a cooperation agreement in the field of education, research and innovation to share knowledge and needs that will allow the development of new health technologies. The agreement establishes a framework for relations between the three institutions for future collaboration in order […]

Leer más about IDIBELL, University Hospital of Bellvitge and UPC collaborate to develop new health technologies

Brain plasticine’ is back

Past April 1st, 2nd and 3rd, students in 1 º ESO at IES Joan Corominas, Premia de Mar and students of 3 º ESO at IES Montjuïc, Barcelona discovered how our brain changes and also how sometimes it deceives us. They participated in the activity ‘ Brain plasticine’ organized by the research group cognition and […]

Leer más about Brain plasticine’ is back

Jaume Reventós: “Together we can move forward”

On Wednesday April 2, the auditorium of the University Hospital of Bellvitge hosted the presentation of the new IDIBELL general manager, Jaume Reventós. The event was attended by members of the delegate Commission of the institution Jordi Alberch , Vice Chancellor of the University of Barcelona ; Alfredo Garcia Director of the University Hospital of […]

Leer más about Jaume Reventós: “Together we can move forward”

Identified epigenetic factors associated with an increased risk of developing cancer

Research shows that in one in four human tumor exist genetic polymorphisms associated with increased risk of cancer that cause epigenetic changes that modifies the expression of neighboring genes.

Leer más about Identified epigenetic factors associated with an increased risk of developing cancer

IDIBELL researchers describe a new tumor suppressor gene in the liver

NOX4 enzyme inhibits the growth of tumor cells in liver Article reference The NADPH oxidase NOX4 inhibits hepatocyte proliferation and liver cancer progression

Leer más about IDIBELL researchers describe a new tumor suppressor gene in the liver

3D biotechnology, protagonist of the workshop of the European project IT-LIVER in Vienna

On February 27th and 28th the University of Vienna hosted the second workshop of the European project IT-Liver, funded by the Marie Curie ITN (Initial Training Network) program of the European Commission (FP7) and coordinated by the head of the Biological clues of the invasive and metastasic phenotype research group at IDIBELL, Isabel Fabregat. In […]

Leer más about 3D biotechnology, protagonist of the workshop of the European project IT-LIVER in Vienna

Discovery of a mechanism that makes tumor cells sugar addicted

For almost a hundred years ago is known that cancer cells feel a special appetite for a type of sugar called glucose. The tumor uses this molecule is like the gasoline which depends a sports car to burn faster and grows and multiplies rapidly. It is a little cash process from the energy point of […]

Leer más about Discovery of a mechanism that makes tumor cells sugar addicted

Antiviral therapy reduces risk if death by 25% in adults hospitalized with influenza

The study was conducted in 29,000 patients during H1N1 pandemic Antiviral treatment Article reference Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data. Online Journal comment Journal comment

Leer más about Antiviral therapy reduces risk if death by 25% in adults hospitalized with influenza

New advances in the study of megalencephalic leukoencephalopathy

Some types of leukodystrophies, that are neurodegenerative hereditary myelin disorders, are characterized by the presence of vacuoles in which myelin lamellae isolate CNS axons . The megalencephalic leukoencephalopathy (MLC), caused by mutations in the gene MLC1 and GlialCAM is a rare disease with appearance of this type of vacuoles, and currently there is no treatment […]

Leer más about New advances in the study of megalencephalic leukoencephalopathy
Scroll to Top